Myrica 50 mg (Capsule)
Unit Price: ৳ 13.50 (3 x 10: ৳ 405.00)
Strip Price: ৳ 135.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Unimed unihealth pharmaceuticals ltd |
| Also available as |
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
Dosage
- Maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min
- Maximum recommended dose of Pregabalin CR capsule is 330 mg once daily
Administration
- Taken in oral route
- Can be taken with or without food
- Pregabalin CR tablet should be administered after an evening meal
- Should be swallowed whole and should not be split, crushed or chewed
Interaction
- Myrica is unlikely to be involved in significant pharmacokinetic drug interactions
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Thinking abnormal
Pregnancy & Lactation
- No adequate and well-controlled studies with pregabalin in pregnant women
- Pregnant women should be advised of the potential risk to a fetus
- Breastfeeding is not recommended during treatment with pregabalin
Precautions & Warnings
- Angioedema can occur and may be associated with life threatening respiratory compromise requiring emergency treatment
- Respiratory depression may occur when used with concomitant CNS depressants or in the setting of underlying respiratory impairment
- May cause dizziness and somnolence and impair patient's ability to drive or operate machinery
- Increased seizure frequency or other adverse reactions may occur if rapidly discontinued
- May cause peripheral edema
- Caution should be exercised when coadministering Myrica and thiazolidinedione antidiabetic agents
Use in Special Populations
- Safety and effectiveness in pediatric patients have not been established for various conditions
Overdose Effects
- Sign and symptoms include reduced consciousness, depression/anxiety, confusional state, agitation and restlessness
- Seizures and heart block have also been reported
- No specific antidote
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
Chemical Structure
- Molecular Formula: C8H17NO2
Common Questions about Myrica 50 mg Capsule
- Anticonvulsant and first-line treatment for neurotic pain, shingles, seizures, and fibromyalgia
- Should be taken till improvement in health conditions
- Dosage as prescribed by the doctor
- Should be taken after food in a prescribed dosage
- Storage instructions: cool dry place, original packaging, unreachable to children and pets
- Works differently for different diseases
- Duration of consumption depends on the condition
- Should not be stopped abruptly without consulting the doctor
- Can be used with Diazepam
- May cause weight gain
- Quick tips for usage and precautions